![Gina M. Wallar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Gina M.
Wallar worked as a Director at LabCorp Clinical Trials.
She then worked at NeoGenomics, Inc. as the President-Pharma Services Division from 2021 to 2022.
Dr. Wallar holds a doctorate degree from the University of California, Los Angeles.
Antiguos cargos conocidos de Gina M. Wallar.
| Empresas | Cargo | Fin |
|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 27/05/2022 |
LabCorp Clinical Trials
 LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Director/Miembro de la Junta | - |
Formación de Gina M. Wallar.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
16
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LabCorp Clinical Trials
LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
- Bolsa de valores
- Insiders
- Gina M. Wallar
